Highlights Qlucore AB

Equities

QCORE

SE0016829824

Market Closed - Nasdaq Stockholm Other stock markets 10:24:58 2024-05-31 am EDT			5-day change	1st Jan Change
8.6 ^SEK	+0.58%		+4.88%	+12.42%

May. 27	Qlucore Initiates Software Development Project for Cancer Diagnostics	MT
May. 27	Qlucore Starts Project After Receiving EU Grant to Advance Personalized Cancer Treatment	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qlucore Initiates Software Development Project for Cancer Diagnostics	May. 27	MT
Qlucore AB Releases Unique AI-Based Solution in the Field of Lung Cancer Subtyping	May. 22	CI
Qlucore Announces the Launch of the Qlucore Omics Explorer Cloud Version	Apr. 08	CI
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Feb. 28	CI
Qlucore Submits Technical Documentation for CE Marking of Pediatric Leukemia Medical Device	Jan. 30	MT
Qlucore Diagnostics for Pediatric Leukemia Takes A Significant Step Closer to Ce Marking	Jan. 30	CI
Sahlgrenska Hospital Invests in Precision Diagnostics with Qlucore AB Insights	Jan. 16	CI
Boehringer Ingelheim Signs Two-Year Agreement with Qlucore	Jan. 11	CI
Qlucore Announces Swedish Innovation Evaluated for Clinical Diagnosis of Pediatric Leukemia	Dec. 13	CI
Qlucore AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Nov. 28	CI
Qlucore AB Reports Earnings Results for the First Quarter Ended July 31, 2023	23-08-30	CI
Qlucore AB Reports Earnings Results for the Fourth Quarter Ended April 30, 2023	23-05-31	CI
Qlucore AB Reports Earnings Results for the Full Year Ended April 30, 2023	23-05-31	CI
Qlucore Launches Qlucore Omics Explorer Version 3.9	23-04-26	CI
Qlucore AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	23-02-28	CI
Qlucore AB Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	22-11-28	CI
Qlucore Software Used in New Project to Prevent Cardiovascular Diseases	22-11-17	CI
Qlucore Receives Patent in Europe	22-09-26	CI
Qlucore Ab Reports Earnings Results for the First Quarter Ended July 31, 2022	22-08-30	CI
Qlucore to Develop Diagnostics Product for Two Blood Cancer Types	22-08-26	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Qlucore AB

Equities

QCORE

SE0016829824

Highlights

Filters